NEWS DETAIL

Percubaan PrCOG 0905: Kemoterapi Intensif Gefitinib vs. Midotuximab Plus untuk Leukemia Myeloid Akut Mutan FLT3 yang Baru Didiagnosis – aml-hub.com

Percubaan PrCOG 0905: Kemoterapi Intensif Gefitinib vs.

Maklumat Perubatan

Kandungan penuh artikel

We summarize the key findings from the phase II PrECOG 0905 trial evaluating the efficacy of gilteritinib vs midostaurin in combination with intensive chemotherapy in patients with newly diagnosed FLT3-mutated AML.

Produk Berkaitan Artikel Ini

Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.

Soalan Lazim

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Gefitinib – Beli Dalam Talian Lucius Gilteritinib – Beli Dalam Talian GILLIDX Gilteritinib 40mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat